MAIA Biotechnology, Inc. (MAIA) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Mar 23, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for MAIA Biotechnology, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, MAIA Biotechnology, Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does MAIA Biotechnology, Inc. actually do?
Answer:
MAIA Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer. Its lead asset, ateganosine (THIO), is an investigational drug candidate designed with a dual mechanism of action targeting telomeres and inducing immunogenicity. Ateganosine is being evaluated in Phase 2 and Phase 3 clinical trials, primarily for Non-Small Cell Lung Cancer (NSCLC), often in combination with immune checkpoint inhibitors like Regeneron's Libtayo. The company has also initiated trials for hepatocellular carcinoma, colorectal cancer, and small cell lung cancer. MAIA Biotechnology aims to position ateganosine as a foundational treatment to prime the immune system for other cancer therapies.
Question:
What are MAIA Biotechnology, Inc.'s revenue drivers?
Answer:
The company has not yet commercialized any products and therefore has no revenue. Future revenue is expected to be driven by the successful development and commercialization of its drug candidates, primarily ateganosine.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required